Due Diligence

Focus on exposure

Kaoru Sakabe
April 1, 2017

In past columns, I’ve made the point that figure preparation begins at data acquisition, but I haven’t really explained my reasoning in depth. So here, I’ll fill you in. Once you’ve snapped your picture or exposed your Western blot, that image becomes the version of record for your experiment. If the data you’ve collected is poor quality from the outset, your figure is already compromised.

Read the entire collection

One way to tell if you’ve nailed your image’s acquisition parameters is to look at your image’s histogram. Being able to interpret the histogram correctly can tell you if you can move forward with snapping the next picture of your mutant phenotype or if you need to tinker with the acquisition settings.

If you’re a digital photography aficionado, you probably are very familiar with histograms and the information they contain. Here’s a quick overview for those not yet accustomed to viewing them: A histogram of an image displays the distribution of pixels in the image, showing a graph of the number of pixels with a given intensity. For an eight-bit grayscale image, there are 256 possible intensities ranging from 0 (black) to 255 (white) for each pixel in the image. The histogram will not tell you how these pixels are distributed in space, just the distribution of the pixel intensity.

Ideally, you want the pixels to lie between the two extremes. This ensures that the fine details of your images are captured. If the pixels are clustered at either end, you’ve likely oversaturated or underexposed your image. For example, aggressively adjusting the black levels of an immunofluorescence image to reduce the background eliminates hallmarks of a true experimental image. On the other hand, oversaturation leads to loss of fine details and makes it impossible to quantify the signal. Why? From the point of view of the detector, i.e., the camera or film, once it has recorded the maximum amount of signal, it cannot register any more. If you’ve hit the limit on either end of the histogram, the detector won’t be able to tell you if a band or a cell feature is two times or 20 times more intense than a neighboring band or cell.

If you’re acquiring images on a microscope or gel-documentation system, the hard part already is done for you, because these instruments typically show you the histogram of the image you’ve just acquired. If you are using film, take multiple exposures of your blot to make sure you are within the linear range of the signal so you can properly quantify it. Once you’ve scanned your film, you can use either Photoshop or ImageJ to look at the histogram of your image. A telltale blip at either end of the histogram will tell you that you need to adjust your acquisition settings or use a different exposure of your film (Figure 1).

The histogram is also useful in telling you if your image has been overadjusted during figure preparation. After you’ve adjusted the brightness or contrast settings of your image, make sure to check the histogram one final time. If the histogram has shifted too far to the left or to the right, you’ve likely truncated the pixels that were at the ends of the distribution, and your image is now overly adjusted (Figure 2). If your histogram shifts too far to either end, the resulting image may raise flags with reviewers or the journal, because it may look like you’re trying to hide something. Remember, there’s no need to hide your true experimental results!

Doing your due diligence at the image-acquisition phase will save you time as you prepare your figures for publication, which could be months or even years after you initially acquired your data. Going back and repeating an experiment because an immunofluorescent image was underexposed or a band was completely blown out can be frustrating, to say the least, so use these tips to make the most out of your data.

Figure 1. A spike on the histogram at 0 (red arrow) indicates that a Western blot was burned out (all black); a spike at 255 would have indicated that the blot was overexposed (all white).Figure 2. (A) The original capture of an immunoblot (B) Some of the levels were adjusted, but the pixels were still distributed between the two extremes. (C) The immunoblot was overly adjusted. The corresponding histogram shifted to the right, indicating that the majority of the pixels now were white.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Kaoru Sakabe

Kaoru Sakabe is the data integrity manager at the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.